Lou Reese

Insider Reports History

Reporting-owner location: Dallas, TX
Latest reporting-owner signature: /s/ Rene Paula Molina as Attorney-in-Fact for Lou Reese
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Lou Reese

Form 4 holding Executive Chairman., Director

Vaxxinity, Inc.

Security class: Stock Option (right to buy)
Shares / value: 301,188
Estimated value
Report date: 07 Mar 2023
Price
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount

Insider Reports Filed by Lou Reese

4

Vaxxinity, Inc.

Report period: 07 Mar 2023
Transactions: 3
Transaction value: $0
Accepted by SEC: 05 Apr 2023, 16:48
Role: Executive Chairman., Director
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 16 Jun 2022
Transactions: 1
Transaction value: +$199,290
Accepted by SEC: 21 Jun 2022, 16:57
Role: Executive Chairman, Director, 10%+ Owner
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 08 Jun 2022
Transactions: 2
Transaction value: +$59,386
Accepted by SEC: 10 Jun 2022, 18:11
Role: Executive Chairman, Director, 10%+ Owner
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 26 Apr 2022
Transactions: 2
Transaction value: +$79,689
Accepted by SEC: 28 Apr 2022, 19:25
Role: Executive Chairman, Director
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 25 Apr 2022
Transactions: 1
Transaction value: +$27,073
Accepted by SEC: 27 Apr 2022, 20:40
Role: Executive Chairman, Director
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 12 Nov 2021
Transactions: 7
Transaction value: +$241,920
Accepted by SEC: 15 Nov 2021, 17:48
Role: Executive Chairman, Director
Next action: Open filing details

3

Vaxxinity, Inc.

Report period: 10 Nov 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 10 Nov 2021, 15:53
Role: Executive Chairman, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .